Research highlights of renal transplantation in 2020: voice from China
10.3969/j.issn.1674-7445.2021.02.006
- VernacularTitle:2020年肾移植研究大盘点——来自中国的声音
- Author:
Zihuan LUO
1
;
Qiquan SUN
Author Information
1. Department of Renal Transplantation, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
- Publication Type:Research Article
- Keywords:
Renal transplantation;
Rejection;
Ischemia-reperfusion injury (IRI);
Novel coronavirus pneumonia;
Single-cell sequencing technology;
Programmed cell death protein-ligand 1;
Carbamylated erythropoietin;
Cell-free DNA;
BK virus associated nephropathy
- From:
Organ Transplantation
2021;12(2):169-
- CountryChina
- Language:Chinese
-
Abstract:
Renal transplantation is the optimal approach to improve the quality of life and restore normal life for patients with end-stage renal diseases.With the development of medical techniques and immunosuppressants, the shortterm survival of renal graft has been significantly prolonged, whereas the long-term survival remains to be urgently solved.Renal ischemia-reperfusion injury (IRI), acute rejection, chronic renal allograft dysfunction, renal fibrosis and other factors are still the major problems affecting the survival of renal graft.Relevant researches have always been hot spots in the field of renal transplantation.Meantime, 2020 is an extraordinary year.The novel coronavirus pneumonia (COVID-19) pandemic severely affects the development of all walks of life.Researches related to renal transplantation have also sprung up.In this article, the frontier hotspots of clinical and basic studies related to renal transplantation and the COVID-19 related researches in the field of renal transplantation in China were reviewed, aiming to provide novel therapeutic ideas and strategies.
